Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Albers

Showing results (101-110 of 130) with videos related to

Pageof 13
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 26, 2023
Health-related quality of life after stereotactic radiosurgery in patients with brain metastasesElaine A C Albers, Kelly M de Ligt, Lonneke V van de Poll-Franse, et al.
Respiratory Research|June 23, 2021
Impact of baseline clinical asthma characteristics on the response to mepolizumab: a post hoc meta-analysis of two Phase III trialsCatherine Lemiere, Camille Taillé, Jason Kihyuk Lee, et al.
The World Allergy Organization Journal|May 22, 2020
Factors that affect blood eosinophil counts in a non-asthmatic population: Post hoc analysis of data from BrazilNamhee Kwon, Emilio Pizzichini, Aruna T Bansal, et al.
Respiratory Medicine|April 22, 2017
Qualitative evaluation of the St George's Respiratory Questionnaire in patients with severe asthmaLinda M Nelsen, Miriam Kimel, Lindsey T Murray, et al.
Physical Review Letters|August 9, 2003
New mechanism for the alpha to omega martensitic transformation in pure titaniumD R Trinkle, R G Hennig, S G Srinivasan, et al.
Chest|April 1, 2023
Albuterol-Budesonide Pressurized Metered Dose Inhaler in Patients With Mild-to-Moderate Asthma: Results of the DENALI Double-Blind Randomized Controlled TrialBradley E Chipps, Elliot Israel, Richard Beasley, et al.
Allergy|May 4, 2019
The clinical benefit of mepolizumab replacing omalizumab in uncontrolled severe eosinophilic asthmaKenneth R Chapman, Frank C Albers, Bradley Chipps, et al.
The Lancet. Respiratory Medicine|April 12, 2017
Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trialGeoffrey L Chupp, Eric S Bradford, Frank C Albers, et al.
Therapeutic Advances in Respiratory Disease|May 3, 2024
Albuterol-budesonide fixed-dose combination rescue inhaler for asthma: a plain language summary of the MANDALA studyAlberto Papi, Bradley E Chipps, Richard Beasley, et al.
JTO Clinical and Research Reports|June 7, 2023
Self-Reported Cognitive Function and Quality of Life in Patients With SCLC in the Hippocampal Avoidance Prophylactic Cranial Irradiation Versus Prophylactic Cranial Irradiation Randomized Phase 3 Trial (NCT01780675)Elaine A C Albers, Haiyan Zeng, Dirk K M De Ruysscher, et al.
Pageof 13

Showing results (101-110 of 130) with videos related to

Sort By:
Pageof 13
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 26, 2023
Health-related quality of life after stereotactic radiosurgery in patients with brain metastasesElaine A C Albers, Kelly M de Ligt, Lonneke V van de Poll-Franse, et al.
Respiratory Research|June 23, 2021
Impact of baseline clinical asthma characteristics on the response to mepolizumab: a post hoc meta-analysis of two Phase III trialsCatherine Lemiere, Camille Taillé, Jason Kihyuk Lee, et al.
The World Allergy Organization Journal|May 22, 2020
Factors that affect blood eosinophil counts in a non-asthmatic population: Post hoc analysis of data from BrazilNamhee Kwon, Emilio Pizzichini, Aruna T Bansal, et al.
Respiratory Medicine|April 22, 2017
Qualitative evaluation of the St George's Respiratory Questionnaire in patients with severe asthmaLinda M Nelsen, Miriam Kimel, Lindsey T Murray, et al.
Physical Review Letters|August 9, 2003
New mechanism for the alpha to omega martensitic transformation in pure titaniumD R Trinkle, R G Hennig, S G Srinivasan, et al.
Chest|April 1, 2023
Albuterol-Budesonide Pressurized Metered Dose Inhaler in Patients With Mild-to-Moderate Asthma: Results of the DENALI Double-Blind Randomized Controlled TrialBradley E Chipps, Elliot Israel, Richard Beasley, et al.
Allergy|May 4, 2019
The clinical benefit of mepolizumab replacing omalizumab in uncontrolled severe eosinophilic asthmaKenneth R Chapman, Frank C Albers, Bradley Chipps, et al.
The Lancet. Respiratory Medicine|April 12, 2017
Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trialGeoffrey L Chupp, Eric S Bradford, Frank C Albers, et al.
Therapeutic Advances in Respiratory Disease|May 3, 2024
Albuterol-budesonide fixed-dose combination rescue inhaler for asthma: a plain language summary of the MANDALA studyAlberto Papi, Bradley E Chipps, Richard Beasley, et al.
JTO Clinical and Research Reports|June 7, 2023
Self-Reported Cognitive Function and Quality of Life in Patients With SCLC in the Hippocampal Avoidance Prophylactic Cranial Irradiation Versus Prophylactic Cranial Irradiation Randomized Phase 3 Trial (NCT01780675)Elaine A C Albers, Haiyan Zeng, Dirk K M De Ruysscher, et al.
Pageof 13